|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
DK171727B1
(da)
|
1978-12-22 |
1997-04-14 |
Biogen Inc |
Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
DE69420137T2
(de)
|
1993-06-03 |
1999-12-23 |
Therapeutic Antibodies, Inc. |
Herstellung von antikörperfragmenten
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
CA2243235C
(en)
|
1996-01-17 |
2010-08-10 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic t lymphocytes (ctl)
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6635742B1
(en)
*
|
2000-01-25 |
2003-10-21 |
Nuvelo, Inc. |
Antibodies specific for semaphorin-like polypeptides
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
|
AU7524601A
(en)
|
2000-06-05 |
2001-12-17 |
Sunol Molecular Corp |
T cell receptor fusions and conjugates and methods of use thereof
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
EP1485075A4
(en)
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
MHC-PEPTIDE COMPLEX BINDING LIGANDS
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
AU2003276403B2
(en)
|
2002-11-09 |
2010-04-15 |
Adaptimmune Limited |
T cell receptor display
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
EP1806358B1
(en)
|
2005-09-05 |
2010-03-17 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
|
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
JP5244103B2
(ja)
*
|
2006-08-09 |
2013-07-24 |
ホームステッド クリニカル コーポレイション |
器官特異的蛋白質およびその使用方法
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
CA2723143A1
(en)
*
|
2008-05-01 |
2009-11-05 |
Martin G. Sanda |
Methods and compositions for prostate cancer immunotherapy
|
|
US20110318380A1
(en)
*
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
WO2012056407A1
(en)
|
2010-10-26 |
2012-05-03 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
EP2917388B1
(en)
|
2012-11-08 |
2016-10-05 |
Roche Diagnostics GmbH |
Nucleic acids encoding chimeric polypeptides for library screening
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
TWI777194B
(zh)
*
|
2013-08-05 |
2022-09-11 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（一）
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201507030D0
(en)
*
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201511191D0
(en)
*
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
*
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201515321D0
(en)
*
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201520563D0
(en)
*
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
US10357550B2
(en)
|
2016-04-06 |
2019-07-23 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
|
|
US11261223B2
(en)
*
|
2016-05-11 |
2022-03-01 |
The University Of Chicago |
Methods of treating cancers with CT45 targeted therapies
|
|
TWI796314B
(zh)
*
|
2017-01-27 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於卵巢癌和其他癌症免疫治療的新型肽和肽組合物
|
|
WO2019007974A1
(en)
*
|
2017-07-07 |
2019-01-10 |
Immatics Biotechnologies Gmbh |
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS
|
|
TWI837109B
(zh)
|
2017-12-28 |
2024-04-01 |
美商磨石生物公司 |
靶向共有抗原之抗原結合蛋白
|
|
TW202016131A
(zh)
*
|
2018-05-16 |
2020-05-01 |
德商英麥提克生物技術股份有限公司 |
用於抗癌免疫治療的肽
|
|
TW202019955A
(zh)
*
|
2018-07-31 |
2020-06-01 |
德商英麥提克生物技術股份有限公司 |
B*07 限制肽和肽組合的抗癌免疫治療和相關方法
|
|
GB201814362D0
(en)
*
|
2018-09-04 |
2018-10-17 |
Treos Bio Zrt |
Composition and process for preparing vaccine
|